Cargando…

Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension

BACKGROUND: ADRB1 (adrenergic receptor beta 1) responds to neuroendocrine stimulations, which have great implications in hypertension. GRK2 (G protein‐coupled receptor kinase 2) is an essential regulator for many G protein‐coupled receptors and subsequent cell signaling cascades, but its role as a r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xuejing, Zhou, Mengli, Wen, Gaiyan, Huang, Yun, Wu, Junru, Peng, Liping, Jiang, Weihong, Yuan, Hong, Lu, Yao, Cai, Jingjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955481/ https://www.ncbi.nlm.nih.gov/pubmed/33372534 http://dx.doi.org/10.1161/JAHA.120.016364

Ejemplares similares

Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure
por: Kang, Sheng, et al.
Publicado: (2015)

Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway
por: Zhao, Kaochang, et al.
Publicado: (2023)

KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure
por: Lee, Jeong Hyun, et al.
Publicado: (2020)

Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction
por: Tian, Xiuqing, et al.
Publicado: (2016)

GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2
por: Thapaliya, Monica, et al.
Publicado: (2022)

Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
por: Liu, Chi, et al.
Publicado: (2018)

Computational study of paroxetine-like inhibitors reveals new molecular insight to inhibit GRK2 with selectivity over ROCK1
por: Keretsu, Seketoulie, et al.
Publicado: (2019)

Reversing T Cell Dysfunction to Boost Glioblastoma Immunotherapy by Paroxetine‐Mediated GRK2 Inhibition and Blockade of Multiple Checkpoints through Biomimetic Nanoparticles
por: Wang, Tingting, et al.
Publicado: (2023)

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
por: Maning, Jennifer, et al.
Publicado: (2020)

The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors
por: Sorriento, Daniela, et al.
Publicado: (2018)

The Antidepressant Paroxetine Reduces the Cardiac Sodium Current
por: Plijter, Ingmar S., et al.
Publicado: (2023)

Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension
por: Deng, Yawen, et al.
Publicado: (2022)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

A Cardiac Amino-Terminal GRK2 Peptide Inhibits Maladaptive Adipocyte Hypertrophy and Insulin Resistance During Diet-Induced Obesity
por: Manaserh, Iyad H., et al.
Publicado: (2022)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Renal denervation attenuates cardiac hypertrophy in spontaneously hypertensive rats via regulation of autophagy
por: Huang, Jionghua, et al.
Publicado: (2017)

GRK2 Mediates Macrophage Polarization by Regulating EP4-cAMP-pCREB Signaling in Ulcerative Colitis and the Therapeutic Effect of Paroxetine on Mice with DSS-Induced Colitis
por: Zhang, Jiawei, et al.
Publicado: (2023)

GRK5 is a regulator of fibroblast activation and cardiac fibrosis
por: Eguchi, Akito, et al.
Publicado: (2021)

Cardiac GRK2 and the Communicative Axis Between Heart and Fat
por: Hill, Bradford G.
Publicado: (2022)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization.
por: Sorriento, Daniela, et al.
Publicado: (2014)

Suitability of GRK Antibodies for Individual Detection and Quantification of GRK Isoforms in Western Blots
por: Reichel, Mona, et al.
Publicado: (2022)

Genetic Polymorphisms in ADRB2 and ADRB1 Are Associated with Differential Survival in Heart Failure Patients Taking β-Blockers
por: Guerra, Leonardo A., et al.
Publicado: (2022)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

ADRB2-Targeting Therapies for Prostate Cancer
por: Kulik, George
Publicado: (2019)

Exercise Training Attenuates Hypertension and Cardiac Hypertrophy by Modulating Neurotransmitters and Cytokines in Hypothalamic Paraventricular Nucleus
por: Jia, Lin-Lin, et al.
Publicado: (2014)

Blockade of PAR‐1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin‐Overexpressing Hypertensive Mice
por: Yokono, Yoshikazu, et al.
Publicado: (2020)

Pyrroloquinoline quinone attenuates isoproterenol hydrochloride-induced cardiac hypertrophy in AC16 cells by inhibiting the NF-κB signaling pathway
por: Wen, Junru, et al.
Publicado: (2020)

DES mutation associated with cardiac hypertrophy and alternating bundle branch block
por: Chen, Ru, et al.
Publicado: (2020)

Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel
por: Lee, Hyang Mi, et al.
Publicado: (2018)

Obesity-related gene ADRB2, ADRB3 and GHRL polymorphisms and the response to a weight loss diet intervention in adult women
por: Saliba, Louise F., et al.
Publicado: (2014)

Investigating changes in β-adrenergic gene expression (ADRB1 and ADRB2) in Takotsubo (stress) cardiomyopathy syndrome; a pilot study
por: Tutgun Onrat, Serap, et al.
Publicado: (2021)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

Paroxetine overdose during pregnancy
por: Acar, Selin, et al.
Publicado: (2021)

Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016)

Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats
por: Jin, Li, et al.
Publicado: (2017)

Association of ADRB2 polymorphism with triglyceride levels in Tongans
por: Naka, Izumi, et al.
Publicado: (2013)

Curcumin Attenuation of Lipopolysaccharide Induced Cardiac Hypertrophy in Rodents
por: Chowdhury, Rupak, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v2i3o7eofabq2qpc7r8li33brf